Latest database descriptions

1 - To evaluate the incidence of cancer mortality (including lung and pleura cancers) in the ARDCO cohort based on work calendar and benign asbestos-related diseases (asbestosis, pleural plaques). 2 - Evaluation of the contribution of CT examinations, thoughts on examination periodicity. 3 - To assess the psychological impact of post-occupational medical surveillance of individuals exposed to asbestos 4 - To evaluate the role of co-exposures to other carcinogens with asbestos pollution in the risk of developing cancer 5 - To contribute to defining the populations at risk of lung cancer 6 - To contribute defining optimal methods for monitoring populations previously exposed to asbestos

Objectives of the registry in the area of public health (access to pre and postnatal diagnostics, monitoring, caring for patients, evaluation):
1) Determine the prevalence of esophageal atresia and of its various anatomical forms.
2) Study the geographical distribution of this malformation
3) Determine mortality at one year for this malformation
4) Evaluate the disparities in care and the changes between the different centers.

Objectives of the registry in the areas of therapy and research:
1) Evaluate if the percentage of antenatal diagnostic and the earliness in care vary in our country over the next few years.
2) Evaluate the effect of the prenatal diagnosis on prevalence.
3) Evaluate the modifications that appeared in the care for newborns having esophageal atresia and the influence of the latter on the future of the patients. Recent modifications in care: installation of a transanatomic sensor, early feeding, abandoning parenteral nutrition, could influence the change (duration of hospitalization, complications) and the future at 1 year.
4) Evaluate the short-term prognosis (surgical complications, duration of hospitalization, duration of reanimation, etc.).
5) Structure and harmonize the care for esophageal atresia across the national territory.

The main objective of the study is the evaluation of 3-year anal carcinoma incidence in patients with anal AIN3 lesions. Secondary objectives are: - To identify patients with an anal AIN3 lesion, risk factors (demographical data, HIV status...), treatment factors (type of therapeutic treatment), virological and immunological factors (HPV genotype, presence or non-presence of P16 and Ki67 proteins) associated with the onset of epidermoid carcinoma of the anus.- To identify if the presence of P16/Ki67 factors and high risk HPV virus is associated with an increased risk of recurrent AIN3 lesions and if this is the case for high-grade dysplasia of the cervix. - To estimate the proportion of adherent patients, and to identify factors associated with compliance monitoring (demographics, HIV status, type of treatment undertaken ...) - to assess the overall feeling of patients towards anal AIN3 lesion therapeutic care.

Study the relation between aging, health, work, and the evolution of this relation over time (on 10 years, actually)